23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
Scope
The report provides information and insights into 23 and Me's, including:
- Overview of the company and its product offering
- Detailed insight into its business model, company type and headquarter
- Information on funding and partnership
- Biography of top management
Reasons to Buy
- Gain insights into 23andMe’s business operations.
- Gain insights into partnership and funding.
- Gain understanding about its technology focus.
Table of Contents
- Company Overview
- Technology Focus
- Product Overview
- Partnership
- Funding
- Key Employees
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Almirall
- Lark Health
- iHeartRadio
- GlaxoSmithKline (GSK)
- NewView Capital
- Sequoia Capital
- Genentech
- New Enterprise Associates
- Mohr Davidow Ventures
